PATRICIA WOODS: Open Payments
NPI 1558032300 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,294 in 66 payments from 25 companies in 2025. Trend: 2023 $425 · 2024 $940 · 2025 $1,294
Food & beverage: $1,294
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $217 |
| AstraZeneca Pharmaceuticals LP | 9 | $165 |
| Axsome Therapeutics, Inc. | 8 | $147 |
| Corcept Therapeutics | 4 | $93 |
| Lilly USA, LLC | 4 | $74 |
| Henry Schein, Inc. | 1 | $59 |
| PFIZER INC. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
Products named: Auvelity, UBRELVY, AIRSUPRA, Korlym, VRAYLAR, MOUNJARO, TRINTELLIX, CAPLYTA.
Industry payments across ID — which companies pay providers there.
